SYNERON MEDICAL LTD Value Stock - Dividend - Research Selection
Market price: 0,00 USD
SYNERON MEDICAL LTD Fundamental data and company key figures of the share
|Annual reports in USD|
|Net operating cash flow||8.360.000|
|Free cash flow||4.511.000|
|Liabilities & Shareholders equity||277.185.000|
|Diluted shares outstanding||34.945.000|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||384.395.008,00 USD|
|Raw Data Source|
Description of the company
Syneron Medical Ltd., designs, develops and markets aesthetic medical products based on its various technologies including its Electro-Optical Synergy (ELOS), technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. The CompanyÂ´s products, which it sells primarily to physicians and other practitioners, target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skinÂ´s appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference and laser-assisted lipolysis. On February 13, 2012, the Company acquired Ultrashape Ltd. On March 14, 2012, Syneron acquired substantially all the assets of TransPharma Medical Ltd.